TheEdgeResearch
Home / Stocks / BSSP

Baseline Productions, Inc. (BSSP)

OTC Healthcare Biotechnology
$0.00 ▲ +0.00%
Market Cap
$74,377
Sector
Healthcare
Industry
Biotechnology
Beta
0.00
52-Wk Range
0.0001-0.0002
CEO
Dennis R. Alexander
Country
US
Currency
USD

Baseline Productions, Inc. operates in the Biotechnology industry of the Healthcare sector, headquartered in Scottsdale, AZ, US. The stock last traded at $0.00, up 0.00% on the session, giving a market capitalisation of $74,377. On trailing twelve-month figures it carries a trailing P/E of -0.02, a net margin of 0.0%. Its beta of 0.00 implies it has historically moved less than the broad market.

Valuation & profitability (TTM)
P/E
-0.02
Price / Sales
0.00
Price / Book
-0.02
EV / EBITDA
-1.52
Gross margin
0.0%
Operating margin
0.0%
Net margin
0.0%
Return on equity
Debt / equity
-0.61
Current ratio
0.15
Dividend yield
0.0%
Payout ratio
0.0%
Company profile
Exchange
Other OTC
Employees
0
IPO date
2012-12-13
Headquarters
Scottsdale, AZ, US
About Baseline Productions, Inc.

As of 2021, Baseline Productions, Inc. is actively pursuing opportunities for a merger or acquisition. Simultaneously, the company is working to bring its operations and status up-to-date. This strategic shift follows a significant development on October 9, 2017, when its Pharmaceutical Services Agreement (PSA) with Canteck Pharma, Inc. was terminated. The reason for this termination was the company's inability to secure the necessary licensing to proceed with its immunotherapeutic-based technology, which was specifically targeted at cancer indications, within Mexico.

Comparable companies

Baseline Productions, Inc. is most often compared with the following Healthcare names:

ACBMAFFYAMBSDECNENDVGNLKQITMCNSPDFPRMDSXHHF
More research on BSSP
BSSP technical analysis BSSP TheEdge Score Compare against peers
Open full interactive analysis & DCF →